| Jeanne Madden, CRNA | |
|
411 W Tipton St, Seymour, IN 47274-2363 | |
| (812) 522-2349 | |
| Not Available |
| Full Name | Jeanne Madden |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 33 Years |
| Location | 411 W Tipton St, Seymour, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326068438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 28078209A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Gastroenterology Llc | 5092051896 | 8 |
News Archive
In April 2009, researchers at UCLA announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
Research released today in the American Journal of Public Health found evidence that the tobacco industry has manipulated menthol levels and created new cigarette brands with the intention of gaining market share among young adults and adolescents.
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 7 days ago
| Entity Name | Midwest Gastroenterology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528550241 PECOS PAC ID: 5092051896 Enrollment ID: O20190116001102 |
News Archive
In April 2009, researchers at UCLA announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
Research released today in the American Journal of Public Health found evidence that the tobacco industry has manipulated menthol levels and created new cigarette brands with the intention of gaining market share among young adults and adolescents.
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeanne Madden, CRNA 4808 Chervil Ct, Indianapolis, IN 46237-3714 Ph: () - | Jeanne Madden, CRNA 411 W Tipton St, Seymour, IN 47274-2363 Ph: (812) 522-2349 |
News Archive
In April 2009, researchers at UCLA announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.
A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.
Research released today in the American Journal of Public Health found evidence that the tobacco industry has manipulated menthol levels and created new cigarette brands with the intention of gaining market share among young adults and adolescents.
Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved Forxiga (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union. Forxiga is a selective and reversible inhibitor of sodium-glucose cotransporter 2 (SGLT2) that works independently of insulin to help remove excess glucose from the body, a unique mode of action not seen in any other currently available treatments for type 2 diabetes.
› Verified 7 days ago
Mr. Robert Judge, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-522-2349 | |
Karen S Stumpf, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-522-2349 | |
Mr. David Lynn Proffer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-522-0429 |